GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Creo Medical Group PLC (STU:1RC) » Definitions » Debt-to-Asset

Creo Medical Group (STU:1RC) Debt-to-Asset : 0.11 (As of Dec. 2023)


View and export this data going back to 2016. Start your Free Trial

What is Creo Medical Group Debt-to-Asset?

Creo Medical Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €3.60 Mil. Creo Medical Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was €6.04 Mil. Creo Medical Group's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2023 was €88.91 Mil. Creo Medical Group's debt to asset for the quarter that ended in Dec. 2023 was 0.11.


Creo Medical Group Debt-to-Asset Historical Data

The historical data trend for Creo Medical Group's Debt-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Creo Medical Group Debt-to-Asset Chart

Creo Medical Group Annual Data
Trend Feb14 Feb15 Feb16 Jun17 Dec19 Dec20 Dec21 Dec22 Dec23
Debt-to-Asset
Get a 7-Day Free Trial Premium Member Only 0.01 0.13 0.11 0.16 0.11

Creo Medical Group Semi-Annual Data
Feb14 Feb15 Feb16 Dec16 Jun17 Dec17 Jun18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Debt-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.11 0.14 0.16 0.10 0.11

Competitive Comparison of Creo Medical Group's Debt-to-Asset

For the Medical Devices subindustry, Creo Medical Group's Debt-to-Asset, along with its competitors' market caps and Debt-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Creo Medical Group's Debt-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Creo Medical Group's Debt-to-Asset distribution charts can be found below:

* The bar in red indicates where Creo Medical Group's Debt-to-Asset falls into.



Creo Medical Group Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Creo Medical Group's Debt-to-Asset for the fiscal year that ended in Dec. 2023 is calculated as

Creo Medical Group's Debt-to-Asset for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Creo Medical Group  (STU:1RC) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Creo Medical Group Debt-to-Asset Related Terms

Thank you for viewing the detailed overview of Creo Medical Group's Debt-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


Creo Medical Group (STU:1RC) Business Description

Traded in Other Exchanges
Address
Beaufort Park Way, Unit 2, Creo House, Beaufort Park, Chepstow, GBR, NP16 5UH
Creo Medical Group PLC is a medical device company engaged in providing services in the field of surgical endoscopy. The company has developed a platform called Croma which is an electrosurgical platform to deliver microwave and bipolar radiofrequency through a single accessory port. The reportable segment of the company is the research and development of electrosurgical medical devices relating to the field of surgical endoscopy.

Creo Medical Group (STU:1RC) Headlines

No Headlines